Fajardo, Cherry Mae T.

HRN: 19-16-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2025
CEFTRIAXONE 1G (VIAL)
06/01/2025
06/08/2025
IV
2g
OD
For OR
Remove - Pending Acceptance
06/01/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/01/2025
06/08/2025
IV
500mg
Q8
For Cholecystectomy
Remove - Pending Acceptance
06/03/2025
METRONIDAZOLE 500MG (TAB)
06/03/2025
06/09/2025
PO
500mg
Q8
Post Op
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: